|
Sign In to gain access to subscriptions and/or personal tools.
|
Isocyanate-terminated Lactic Acid Oligomers as a New Means to Conjugate Functional Drugs or Polymers with Bioresorbable Hydrophobic Segments
Hélène Van Den Berghe
Max Mousseron Institut of Biomolecules, UMR CNRS 5247 Faculty of Pharmacy, Bat. I, 15 avenue Charles Flahault 34093 Montpellier Cedex 05, France
Jean Coudane
Max Mousseron Institut of Biomolecules, UMR CNRS 5247 Faculty of Pharmacy, Bat. I, 15 avenue Charles Flahault 34093 Montpellier Cedex 05, France, jcoudane{at}univ-montp1.fr
Michel Vert
Max Mousseron Institut of Biomolecules, UMR CNRS 5247 Faculty of Pharmacy, Bat. I, 15 avenue Charles Flahault 34093 Montpellier Cedex 05, France
The use of poly(lactic acid) with activated chain ends is an alternative strategy to polymerizing lactides using coordination-insertion polymerizations in the presence of alcohols or amines when one wants to create a macromolecular prodrug or to create self-assembling amphiphilic polymers or to modify a surface. A new route to functionalized poly(a-hydroxy acid) end groups is described based on successive reactions; the activation of chain ends via the formation of a mixed anhydride, the conversion to azide, and finally the formation of isocyanate by the Curtius rearrangement, all in one pot. The various stages are monitored using FTIR spectrometry. To exemplify the potential of the method, activated lactic acid oligomers are reacted with model alcohols and amine-bearing small molecules that are bound via carbamate or urea bonds, respectively. FTIR, 1H NMR, and SEC with a refractometric/photo diode array or refractometric/ fluorimetric double detections are used to assess the binding of the drug model on oligomers. Based on the results, the method is easily applied to small molecules, macromolecules, and surfaces bearing chemical functional groups that react with isocyanate.
Key Words: lactic acid polymers bioresorbable polymeric synthon curtius rearrangement urea derivative carbamate derivative polymer—drug conjugates.
References
- Sunamoto, J., Sato, T., Hirota, M., Fukushima, K., Hiratani, K. and Hara, K. (1987). A Newly Developed Immunoliposome: An Egg Phosphatidylcholine Liposome Coated with Pullulan Bearing both a Cholesterol Moiety and an IgMs Fragment, Biochem. Biophys. Acta, 898(3): 323—330.[Medline]
[Order article via Infotrieve]
- Ringsdorf, H. (1975). Structure and Properties of Pharmacologically Active Polymers, Journal of Polymer Science, Polymer Symposium, 51: 135.
- Braud, C. and Vert, M. (1985). In: Polymers as Biomaterials, Shalaby, S.W., Hoffman, A.S., Ratner, B.D. and Horbett, T.A. (eds), pp. 1—15, Plenum Publ. Co, New York.
- Vert, M. (1986). Polyvalent Polymeric Drug Carriers, In: CRC Critical Reviews — Therapeutic Drug Carrier Systems, Bruck, S.D. (ed.) pp. 291—327, CRC Press, Boca Raton.
- Domuurado, D. and Vert, M. (2007) Bioresorbable Polyelectrolyte Amphiphiles as Nanosized Carriers for Lipophilic Drug Solubilization and Delivery, J. Biomaterials Science: Polym. Ed., 18(3): 287—301.[CrossRef]
- Brannon-Peppas, L. and Vert, M. (2000). Polylactic and Polyglycolic Acids as Drug Delivery Carriers, In: Wise, L.R., Klibanov, D.L., Mikos, A., Brannon-Peppas, L., Peppas, N.A., Trantalo, D.J., Wnek, G.E., Michael, J. and Yaszemski, M.J. (eds), Handbook of Pharmaceutical Controlled Release Technology, pp. 90—130, Marcel Dekker, New York.
- Beck, L.R., Flowers, Jr C.E., Pope, V.Z., Tice, T.R., Dunn, R.L. and Gilley, R.M. (1984). In: Long-acting Contraceptive Delivery Systems, Zatuchni, G.L., Goldsmith, A., Shelton, J.D. and Sciarra, J.J. (eds), Vol. 37, p. 407, Harpers and Row Publishers, Philadelphia.
- Hecquet, B., Chabot, F., Delatorre Gonzalez, J.C., Fournier, C., Hilali, S., Cambier, L., Depadt, G. and Vert, M. (1986). In vivo Sustained Release of Cisplatin from Bioresorbable Implants in Mice, Anticancer Research, 6: 1251.[Web of Science][Medline]
[Order article via Infotrieve]
- Cowsar, D.R., Tice, T.R., Gilley, R.M. and English, J.P. (1985). Poly(lactide-co-glycolide) Microcapsules for Controlled Release of Steroids, Methods in Enzymology, 112: 101.[Web of Science][Medline]
[Order article via Infotrieve]
- Zhou, D.S., Zhao, K.B., Li, Y., Cui, F.Z. and Lee, I.S. (2006). Repair of Segmental Defects with Nano-droxyapatite/Collagen/PLA Composite Combined with Mesenchymal Stem Cells, J. Bioact. Compat. Polym., 21: 373—384.[Abstract/Free Full Text]
- Thatte, S., Datar, K. and Ottenbrite, R.M. (2005). Perspectives On: Polymeric Drugs and Drug Delivery Systems, J. Bioact. Compat. Polym., 20: 585—601.[Abstract]
- Ustariz-Peyret, C., Coudane, J., Vert, M., Kaltsatos, V. and Boisramé, B. (2000). Labile Conjugation of a Hydrophilic Drug to PLA Oligomers to Modify a Drug Delivery System: Cephradin in a PLAGA Matrix, J. Microencapsulation, 17(5): 615.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pravata, L., Braud, C., Boustta, M., Abdellaoui-Schwach, K. and Vert, M. Biomacromolecules (submitted).
- Schwach, G., Coudane, J., Engel, R. and Vert, M. (1997). More About the Polymerization of Lactides in the Presence of Stannous Octoate, Journal of Polymer Science, Part A: Polymer Chemistry, 35: 3431—3440.[CrossRef]
- Dyer, E., Taylor, H.A., Mason, S.I. and Samson, I. (1949). The Rates of Reaction of Isocyanates with Alcohols. I. Phenyl Isocyanate with 1- and 2-Butanol, J. Am. Chem. Soc., 71: 4106.[CrossRef][Web of Science]
- Bailey, M.F., Kirss, V. and Spaunburgh, R.G. (1956). Reactivity of Organic Isocyanates, Ind. Eng. Chem., 48: 794.[CrossRef]
- Klinger, D., Chang, J.Y. and Theato, P. (2007). Poly(4-vinylbenzoyl azide): A New Isocyanato Group Generating Polymer, Macromol. Rapid Commun., 28: 718.[CrossRef]
Journal of Bioactive and Compatible Polymers, Vol. 22, No. 6,
637-650 (2007)
DOI: 10.1177/0883911507084413

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|